← Open Payments lookup

DEVON ISAAC: Open Payments

NPI 1124806963 · ABINGDON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$471 in 17 payments from 9 companies in 2025. Trend: 2023 $87 · 2024 $736 · 2025 $471

Food & beverage: $471
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$146
Daiichi Sankyo Inc.3$88
Takeda Pharmaceuticals U.S.A., Inc.2$58
Janssen Biotech, Inc.1$44
Caris MPI, Inc.2$37
Gamida Cell Inc.1$27
Syndax Pharmaceuticals, Inc.1$25
Merck Sharp & Dohme LLC1$24
TerSera Therapeutics LLC1$22

Products named: Enhertu, FRUZAQLA, TECVAYLI, MI CANCER SEEK, Vanflyta, OMISIRGE, KEYTRUDA, Zoladex.

Industry payments across MD — which companies pay providers there.